There are lung cancer patients for whom there are few, very few therapeutic options at the time …
esmo2022
-
-
Measure the level of sodium in the blood using it to find new, more effective biomarkers for …
-
Treating patients first with immunotherapy and then with target therapy has proven to be the best strategy …
-
It is one of the promises of the most advanced research in oncology: the possibility, one day …
-
Health
Cancer of the biliary tract: with the ‘doublet’ immuno-chemotherapy increases survival
by adminAnother good news from the Esmo Congress and this time it concerns those with biliary tract cancer. …
-
It is called an agnostic approach and consists in studying a tumor from a biomolecular and genetic …
-
Health
Prostate cancer: with new therapies the quality of life also improves in metastatic patients
by adminExtending the survival of cancer patients is always the first goal, but with the new drugs we …
-
With a five-year survival rate of only 10%, metastatic non-small cell lung cancer (Nsclc) remains firmly at …
-
The news of the reimbursement approval by the Italian Medicines Agency for osimertinib in the adjuvant treatment …
-
Health
Oncology, from the ‘founding father’ to the young researcher: Italian excellence awarded at Esmo 2022
by adminWe are in Paris, but the Italian flag flies high here at Esmo where two important awards …